| Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers S Havervall, A Rosell, M Phillipson, SM Mangsbo, P Nilsson, S Hober, ... Jama 325 (19), 2015-2016, 2021 | 445 | 2021 |
| Neutrophil extracellular traps: villains and targets in arterial, venous, and cancer-associated thrombosis C Thålin, Y Hisada, S Lundström, N Mackman, H Wallén Arteriosclerosis, thrombosis, and vascular biology 39 (9), 1724-1738, 2019 | 369 | 2019 |
| SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ... Nature communications 11 (1), 5064, 2020 | 347 | 2020 |
| Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer C Thålin, S Lundström, C Seignez, M Daleskog, A Lundström, ... PloS one 13 (1), e0191231, 2018 | 213 | 2018 |
| Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality—brief report A Rosell, S Havervall, F von Meijenfeldt, Y Hisada, K Aguilera, SP Grover, ... Arteriosclerosis, Thrombosis, and Vascular Biology 41 (2), 878-882, 2021 | 202 | 2021 |
| Anti-spike mucosal IgA protection against SARS-CoV-2 omicron infection S Havervall, U Marking, J Svensson, N Greilert-Norin, P Bacchus, ... New England Journal of Medicine 387 (14), 1333-1336, 2022 | 196 | 2022 |
| Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19 H Ng, S Havervall, A Rosell, K Aguilera, K Parv, FA von Meijenfeldt, ... Arteriosclerosis, thrombosis, and vascular biology 41 (2), 988-994, 2021 | 193 | 2021 |
| NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation C Thålin, M Demers, B Blomgren, SL Wong, M von Arbin, A von Heijne, ... Thrombosis research 139, 56-64, 2016 | 170 | 2016 |
| Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors Y Hisada, SP Grover, A Maqsood, R Houston, C Ay, DF Noubouossie, ... haematologica 105 (1), 218, 2019 | 146 | 2019 |
| Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma C Thålin, M Daleskog, SP Göransson, D Schatzberg, J Lasselin, ... Immunologic research 65, 706-712, 2017 | 142 | 2017 |
| Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers A Lundström, L Ziegler, S Havervall, AS Rudberg, F von Meijenfeldt, ... Journal of Medical Virology 93 (10), 5908-5916, 2021 | 67 | 2021 |
| Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19 S Havervall, H Ng, A Jernbom Falk, N Greilert‐Norin, A Månberg, ... Journal of internal medicine 291 (1), 72-80, 2022 | 65 | 2022 |
| Quantification of citrullinated histones: Development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma C Thålin, K Aguilera, NW Hall, MR Marunde, JM Burg, A Rosell, ... Journal of Thrombosis and Haemostasis 18 (10), 2732-2743, 2020 | 64 | 2020 |
| 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection U Marking, O Bladh, S Havervall, J Svensson, N Greilert-Norin, K Aguilera, ... The Lancet Infectious Diseases 23 (2), 150-152, 2023 | 52 | 2023 |
| SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection S Havervall, A Jernbom Falk, J Klingström, H Ng, N Greilert-Norin, ... PLoS One 17 (1), e0262169, 2022 | 51 | 2022 |
| Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2 S Havervall, U Marking, N Greilert-Norin, H Ng, M Gordon, ... EBioMedicine 70, 2021 | 49 | 2021 |
| Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma R Zenlander, S Havervall, M Magnusson, J Engstrand, A Ågren, C Thålin, ... Scientific Reports 11 (1), 18025, 2021 | 41 | 2021 |
| Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection K Blom, U Marking, S Havervall, NG Norin, M Gordon, M García, ... The Lancet Infectious Diseases 22 (7), 943-945, 2022 | 40 | 2022 |
| Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants V Monteil, B Eaton, E Postnikova, M Murphy, B Braunsfeld, I Crozier, ... EMBO Molecular Medicine 14 (8), e15230, 2022 | 39 | 2022 |
| Mucosal IgA against SARS-CoV-2 Omicron Infection. Reply. M Åberg, A Smed-Sörensen, C Thålin The New England journal of medicine 387 (21), e55-e55, 2022 | 38 | 2022 |
